Addex Therapeutics Ltd (ADXN)
11.01
+0.31
(+2.90%)
USD |
NASDAQ |
Nov 04, 13:30
Addex Therapeutics Revenue (Quarterly): 0.1275M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.1275M |
| March 31, 2024 | 0.2671M |
| December 31, 2023 | 0.1731M |
| September 30, 2023 | 0.3711M |
| June 30, 2023 | 0.7019M |
| March 31, 2023 | 0.5409M |
| December 31, 2022 | 0.6157M |
| September 30, 2022 | 0.4239M |
| June 30, 2022 | 0.19M |
| March 31, 2022 | 0.2568M |
| December 31, 2021 | 0.4312M |
| Date | Value |
|---|---|
| September 30, 2021 | 0.7429M |
| June 30, 2021 | 1.090M |
| March 31, 2021 | 0.9333M |
| December 31, 2020 | 2.014M |
| September 30, 2020 | 0.0296M |
| June 30, 2020 | 0.8932M |
| March 31, 2020 | 0.9343M |
| December 31, 2019 | 1.051M |
| September 30, 2019 | 0.5099M |
| June 30, 2019 | 0.518M |
| March 31, 2019 | 0.7034M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0296M
Minimum
Sep 2020
2.014M
Maximum
Dec 2020
0.6204M
Average
0.5409M
Median
Mar 2023
Revenue (Quarterly) Benchmarks
| AC Immune SA | 0.7596M |
| CRISPR Therapeutics AG | -- |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 1.715M |
| MoonLake Immunotherapeutics | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 14.24M |
| Total Expenses (Quarterly) | 1.122M |
| EPS Diluted (Quarterly) | 10.62 |
| Enterprise Value | 7.218M |
| Earnings Yield | -14.92% |
| Normalized Earnings Yield | -96.68 |